Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 10, 2013, Pages 1185-1197

  Wang, Xing Hua ^a   Li, Shuang ^b   Liang, Liang ^c   Xu, Xiao Ding ^d   Zhang, Xian Zheng ^d   Jiang, Fa Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL HOSPITAL OF WUHAN   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

biocompatibility; peptide hydrogel; rabbit eye; suprachoroidal space; vitreous cavity

Indexed keywords

DRUG DELIVERY SYSTEM; FLUORESCEIN ANGIOGRAPHY; HISTOLOGICAL OBSERVATIONS; PEPTIDE HYDROGELS; POSTERIOR SEGMENT; RABBIT EYE; SUPRACHOROIDAL SPACE; VITREOUS CAVITY;

BIOCOMPATIBILITY; BIODEGRADATION; DRUG DELIVERY; DYES; PEPTIDES; TISSUE; ULTRASONIC IMAGING;

HYDROGELS;

ARGINYLGLYCYLASPARTIC ACID;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; ECHOGRAPHY; FOLLOW UP; HYDROGEL; NONHUMAN; OBSERVATIONAL STUDY; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; RABBIT; RETINA BLOOD VESSEL; RETINA FLUORESCEIN ANGIOGRAPHY; SUSTAINED RELEASE PREPARATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; EYE; HYDROGEL; OLIGOPEPTIDES; RABBITS; VITREOUS BODY;

ORYCTOLAGUS CUNICULUS;

EID: 84878723004     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2012.745714     Document Type: Article

References (26)

1. Loftsson T, Sigurdsson HH, Konradsdottir F, Gisladottir S, Jansook P, Stefansson E. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie. 2008;63:171-179.
2. Colthurst MJ, Williams RL, Hiscott PS, Grierson I. Biomaterials used in the posterior segment of the eye. Biomaterials. 2000;21:649-665.
3. Brandl F, Kastner F, Gschwind RM, Blunk T, Tessmar J, Gopferich A. Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics. J. Controlled Release. 2010;142:221-228.
4. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2001;53:321-339.
5. Leach JB, Schmidt CE. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials. 2005;26: 125-135.
6. Chen MC, Tsai HW, Liu CT, Peng SF, Lai WY, Chen SJ, Chang Y, Sung HW. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. Biomaterials. 2009;30:2102-2111.
7. Li Z, Guan J. Thermosensitive hydrogels for drug delivery. Expert Opin. Drug Deliv. 2011;8:991-1007.
8. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in selfassembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials. 2011;32:5906-5914.
9. Lutolf MP. Biomaterials: spotlight on hydrogels. Nat. Mater. 2009;8:451-453.
10. Myung D, Duhamel PE, Cochran JR, Noolandi J, Ta CN, Frank CW. Development of hydrogelbased keratoprostheses: a materials perspective. Biotechnol. Prog. 2008;24:735-741.
11. Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S. Vitreous substitutes: a comprehensive review. Surv. Ophthalmol. 2011;56:300-323.
12. Bourges JL, Bloquel C, Thomas A, Froussart F, Bochot A, Azan F, Gurny R, BenEzra D, Behar-Cohen F. Intraocular implants for extended drug delivery: therapeutic applications. Adv. Drug. Deliv. Rev. 2006;58:1182-1202.
13. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol. Vis. Sci. 2000;41:961-964.
14. Liang L, Xu XD, Chen CS, Fang JH, Jiang FG, Zhang XZ, Zhuo RX. Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye. J. Biomed. Mater. Res. B. Appl. Biomater. 2010;93:324-332.
15. Liang L, Xu XD, Zhang XZ, Feng M, Peng C, Jiang FG. Prevention of filtering surgery failure by subconjunctival injection of a novel peptide hydrogel into rabbit eyes. Biomed. Mater. 2010;5:045008.
16. Xu XD, Liang L, Chen CS, Lu B, Wang NL, Jiang FG, Zhang XZ, Zhuo RX. Peptide hydrogel as an intraocular drug delivery system for inhibition of postoperative scarring formation. ACS Appl. Mater. Interfaces. 2010;2:2663-2671.
17. Einmahl S, Savoldelli M, D'Hermies F, Tabatabay C, Gurny R, Behar-Cohen F. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest. Ophthalmol. Vis. Sci. 2002;43:1533-1539.
18. Pitkanen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol. Vis. Sci. 2005;46: 641-646.
19. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest. Ophthalmol. Vis. Sci. 1995;36:1893-1903.
20. Olsen TW, Feng X, Wabner K, Conston SR, Sierra DH, Folden DV, Smith ME, Cameron JD. Cannulation of the suprachoroidal space. a novel drug delivery methodology to the posterior segment. Am. J. Ophthalmol. 2006;142:777-787.
21. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2006;355:1419-1431.
22. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 2006;90:1344-1349.
23. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004;122:564-572.
24. Olsen TW, Feng X, Wabner K, Csaky K, Pambuccian S, Cameron JD. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol. Vis. Sci. 2011;52:4749-4756.
25. Perale G, Rossi F, Santoro M, Marchetti P, Mele A, Castiglione F, et al. Drug release from hydrogel: a new understanding of transport phenomena. J. Biomed. Nanotechnol. 2011;7: 476-481.
26. Einmahl S, Ponsart S, Bejjani RA, D'Hermies F, Savoldelli M, Heller J, et al. Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation. J. Biomed. Mater. Res. A. 2003;67:44-53.